Caris Life Sciences: Guidance Raised, Valuation Still Attractive (NASDAQ:CAI)
· seekingalpha.com
Caris Life Sciences (CAI) Q2 beats with raised guidance, margin expansion and Caris Detect launch.
My name is María Fernanda and I'm currently studying an MBA. My inspiration investors are Warren Buffett, Peter Lynch and Terry Smith, so I look for quality co...